Visitor information – Everything you need to know about visiting our sites.
Visitor information – Everything you need to know about visiting our sites.
Our research aims to identify pathways linking inflammation and thrombosis and to develop novel therapeutics targeted to specific vascular beds.
We have developed novel endothelial-targeted therapeutics with specificity to activated vascular beds, thereby delivering benefit with minimal systemic bleeding compromise.
Our group is also developing state-of-the-art platforms based on microfluidic technology to screen chemical libraries for anti-thrombotic potential and develop point-of-care devices for the diagnosis and management of haemostatic disorders.